Staffan Encrantz - Jun 8, 2023 Form 4/A - Amendment Insider Report for Sight Sciences, Inc. (SGHT)

Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz
Stock symbol
SGHT
Transactions as of
Jun 8, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/16/2023, 05:35 PM
Date Of Original Report
Jun 12, 2023
Previous filing
Aug 5, 2022
Next filing
Nov 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Award $0 +11.9K $0.00 11.9K Jun 8, 2023 Direct F1
transaction SGHT Common Stock Award $0 +15.1K +126.42% $0.00 27K Jun 8, 2023 Direct F2
holding SGHT Common Stock 1.18M Jun 8, 2023 See footnote F3
holding SGHT Common Stock 4.02M Jun 8, 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the vesting in full of 11,940 restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program (the "Program"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").
F2 Reflects a grant of RSUs made to the Reporting Person under the Program. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Issuer's board of directors through such vesting date.
F3 These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any. These shares include 632,456 shares of Common Stock that were previously distributed by Allegro Investors LLC to the Trust (its sole member) for no consideration.
F4 These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.

Remarks:

This amendment is being filed to report the shares of Common Stock, that were beneficially owned by the Reporting Person as of June 12, 2023, which were inadvertently omitted in the original Form 4.